Get the Stockscreener App
494.04
0.31%
1.53
After Hours:
495.00
0.96
+0.19%
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $494.04, with a volume of 3.19M.
It is up +0.31% in the last 24 hours and up +5.29% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$492.51
Open:
$489.83
24h Volume:
3.19M
Relative Volume:
1.42
Market Cap:
$183.60B
Revenue:
$45.20B
Net Income/Loss:
$6.87B
P/E Ratio:
27.16
EPS:
18.1888
Net Cash Flow:
$6.75B
1W Performance:
+10.21%
1M Performance:
+5.29%
6M Performance:
-15.57%
1Y Performance:
+22.65%
1-Day Range:
$483.50
$496.28
1-Week Range:
$443.61
$499.00
52-Week Range:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
494.04 | 183.03B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
179.87 | 129.29B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
566.79 | 44.45B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
135.98 | 38.25B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
378.16 | 37.66B | 3.77B | 449.25M | 240.68M | 7.8556 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-27-26 | Initiated | DZ Bank | Buy |
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher Scientific (TMO) Stock Valuation Analysis Reveals Mixed Signals - GuruFocus
Thermo Fisher Scientific Expands Orbitrap Innovation Across Research, Biopharma and Applied Testing at ASMS 2026 - The Joplin Globe
Thermo Fisher Scientific debuts Orbitrap and AI tools at ASMS 2026 - SelectScience
Thermo Fisher Unveils AI Orbitraps And Swedish Labs As Valuation Lags - Yahoo Finance
Thermo Fisher Scientific Stock: Why Analyst Consensus Is 27 Buys With Zero Sells - TIKR.com
Thermo Fisher Rose 10% This Week. Here’s What to Expect in 2026 - TIKR.com
Thermo Fisher Beats Black Worker’s Race, Sex Discrimination Suit - Bloomberg Law News
Thermo Fisher Scientific Hits Day High with 6.8% Intraday Surge - Markets Mojo
Fidelity files Form 144: TMO proposed sale of 45,940 shares (05/29/2026) - Stock Titan
Is Thermo Fisher Scientific Stock Underperforming the S&P 500? - Yahoo Finance
Thermo Fisher (TMO) Surges 6.8%: Is This an Indication of Further Gains? - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MSN
Thermo Fisher Scientific Inc (TMO) Stock Up 6.8% and Still Under - GuruFocus
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 5.14% on May 28: Drivers Behind the Movement - TradingKey
Thermo Fisher Launches E-Gel Power Snap Lite System - Contract Pharma
Thermo Fisher Scientific on Pace for Largest Percent Increase Since October 2025 — Data Talk - Morningstar
Thermo Fisher Scientific on Pace for Largest Percent Increase Since October 2025 -- Data Talk - Moomoo
Thermo Fisher (TMO) Unveils Advanced Mass Spectrometers at Key C - GuruFocus
New Thermo Fisher AI tools aim to speed drug discovery workflows - Stock Titan
Is Thermo Fisher Scientific Inc. (TMO) a Buy as RBC Restarts Coverage With Sector Perform Rating? - Insider Monkey
Thermo Fisher (TMO) Sets a Bold 7% Annual Growth Target at Its 2026 Investor Day - Insider Monkey
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Jefferies Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $650 - Moomoo
[144] THERMO FISHER SCIENTIFIC INC. SEC Filing - Stock Titan
Thermo Fisher Scientific Inc. (TMO) Analyst/Investor DaySlideshow (NYSE:TMO) 2026-05-26 - Seeking Alpha
Thermo Fisher Scientific (TMO) Announces Results of Annual Share - GuruFocus
KeyBanc reiterates Thermo Fisher Scientific stock rating on AI tailwinds By Investing.com - Investing.com Canada
Thermo Fisher Scientific Inc. 8-K SEC Filing Details, Exchange Listings, and Security Information (May 20, 2026) - Minichart
Thermo Fisher Scientific Inc (TMO) Stock Price, Trades & News - GuruFocus
Thermo Fisher (NYSE: TMO) holders back board but reject 2026 executive pay proposal - Stock Titan
[Latest] Global Bioprocess Automation Software Market Size/Share Worth USD 6.19 Billion by 2035 at a 14 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
How Ambient Air Quality Monitoring is Helping Cities Tackle Urban Pollution - AZoCleantech
Thermo Fisher Scientific Inc. (TMO) Announces Opening of New Bioanalytical and Biomarker Laboratory in Gothenburg, Sweden - Insider Monkey
Thermo Fisher Scientific Inc Investor Day Transcript - GuruFocus
Did Thermo Fisher’s AI-Focused Investor Day and Clario Deal Just Redefine TMO’s Investment Narrative? - simplywall.st
Thermo Fisher (TMO) director gets 499-share award, 80 withheld for tax - Stock Titan
Director at Thermo Fisher (NYSE: TMO) granted new shares - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 499-share stock award - Stock Titan
Thermo Fisher (NYSE: TMO) director receives 499-share equity grant - Stock Titan
Thermo Fisher (TMO) director receives 499-share stock grant, now holds 2,602 - Stock Titan
Thermo Fisher (TMO) director Tyler Jacks receives 499-share stock grant - Stock Titan
Director at Thermo Fisher (NYSE: TMO) awarded 499 common shares - Stock Titan
Thermo Fisher (TMO) director Ruby R. Chandy receives 499-share stock grant - Stock Titan
Director at Thermo Fisher (NYSE: TMO) receives 499-share stock grant - Stock Titan
Nuvation Bio (NUVB) Collaborates with Thermo Fisher - Insider Monkey
What Thermo Fisher CEO Said at Investor Day That the Market Is Still Processing - TIKR.com
A Quick Look at Today's Ratings for Thermo Fisher Scientific(TMO.US), With a Forecast Between $600 to $630 - Moomoo
Stifel Maintains Thermo Fisher Scientific(TMO.US) With Buy Rating, Maintains Target Price $600 - Moomoo
Thermo Fisher Scientific To Go Ex-Dividend On June 15th, 2026 With 0.47 USD Dividend Per Share - Moomoo
What Thermo Fisher Scientific (TMO)'s New Gothenburg Lab Expansion Means For Shareholders - Yahoo Finance
D1 Capital Partners L.P.'s Thermo Fisher Scientific Inc(TMO) Holding History - GuruFocus
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.53%
0.58%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):